Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An association study of debrisoquine hydroxylase (CYP2D6) polymorphisms in schizophrenia.

Psychiatric genetics - 1 Jan 1994

Dawson E, Powell J F, Nöthen M M, Crocq M A, Lanczik M, Körner J, Rietschel M, van Os J, Wright P, Gill M

Abstract excerpt

The cytochrome P450 mono-oxygenases are a group of enzymes that metabolize a variety of exogenous and endogenous compounds, some of which are potentially toxic. Individual variations in the metabolism of potential toxins could influence susceptibility to disorders having genetic and environmental components, such as schizophrenia. The frequency of two common mutant alleles of the gene for the cytochrome P450...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Gene Frequency
Share to Point Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Polymerase Chain Reaction

Share to Polymorphism, Genetic

Share to Polymorphism, Restriction Fragment Length

Share to Sequence Deletion

Share to White People

Source

Identifiers

PMID: 7712118
DOI: 10.1097/00041444-199400440-00005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An association study of debrisoquine hydroxylase (CYP2D6) polymorphisms in schizophrenia.PMID 7712118Read ↗

Lack of association between debrisoquine 4-hydroxylase (CYP2D6) gene polymorphisms and schizophrenia.Semantic proximity Read ↗

Debrisoquine 4-hydroxylase (CYP2D6) genetic polymorphisms and susceptibility to schizophrenia in Chinese patients from Taiwan.Semantic proximity Read ↗

No association between schizophrenia and polymorphisms within the genes for debrisoquine 4-hydroxylase (CYP2D6) and the dopamine transporter (DAT).Semantic proximity Read ↗

Pharmacogenetics of Debrisoquine and its Use as a Marker For CYP2D6 Hydroxylation CapacitySemantic proximity Read ↗

PCR-based genotyping for duplicated and deleted CYP2D6 genes.Semantic proximity Read ↗

Genetic polymorphism of debrisoquine oxidation: restriction fragment analysis and allele-specific amplification of mutant alleles of CYP2D6.Semantic proximity Read ↗

Genetic basis for differences in debrisoquin polymorphism between a Spanish and other white populations.Semantic proximity Read ↗

Genetic polymorphism and Parkinson's disease in Taiwan: study of debrisoquine 4-hydroxylase (CYP2D6).Semantic proximity Read ↗

Mutant debrisoquine hydroxylation genes in Parkinson's disease.Semantic proximity Read ↗

The human CYP2D locus associated with a common genetic defect in drug oxidation: a G1934----A base change in intron 3 of a mutant CYP2D6 allele results in an aberrant 3' splice recognition site.Semantic proximity Read ↗

Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease.Semantic proximity Read ↗

Identification of the primary gene defect at the cytochrome P450 CYP2D locus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.